1. Home
  2. TALO vs VCEL Comparison

TALO vs VCEL Comparison

Compare TALO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Talos Energy Inc.

TALO

Talos Energy Inc.

N/A

Current Price

$15.01

Market Cap

2.7B

Sector

Energy

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$57.65

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TALO
VCEL
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.1B
IPO Year
2017
1996

Fundamental Metrics

Financial Performance
Metric
TALO
VCEL
Price
$15.01
$57.65
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$21.33
★ $65.43
AVG Volume (30 Days)
★ 2.7M
854.0K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 60.00
EPS
N/A
★ 0.19
Revenue
★ $1,780,070,000.00
$276,259,000.00
Revenue This Year
$31.44
$24.98
Revenue Next Year
$1.94
$15.37
P/E Ratio
★ N/A
$307.05
Revenue Growth
N/A
★ 16.45
52 Week Low
$10.33
$28.95
52 Week High
$18.76
$59.75

Technical Indicators

Market Signals
Indicator
TALO
VCEL
Relative Strength Index (RSI) 37.97 71.44
Support Level $13.96 $31.72
Resistance Level $15.96 $59.75
Average True Range (ATR) 0.74 2.58
MACD -0.07 0.38
Stochastic Oscillator 32.80 89.11

Price Performance

Historical Comparison
TALO
VCEL

About TALO Talos Energy Inc.

Talos Energy Inc is an independent oil and gas company predominantly involved in offshore exploration and production. The company has operations in the United States, the Gulf of Mexico, and offshore Mexico. The company's operating segments are; exploration and production of oil, natural gas and NGLs, and the CCS segment. Its revenue is generated from the sale of oil, natural gas, and NGL quantities sold to purchasers.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: